Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-05 5:19 pm Purchase | 2025-05-29 | 13G | PlayAGS, Inc. AGS | Glazer Capital, LLC | 2,310,360 5.570% | 2,310,360 (New Position) | Filing History |
| 2025-06-04 5:24 pm Purchase | 2025-05-28 | 13G | Vigil Neuroscience, Inc. VIGL | Glazer Capital, LLC | 2,513,462 5.390% | 2,513,462 (New Position) | Filing History |
| 2025-06-04 5:09 pm Purchase | 2025-05-28 | 13G | Inozyme Pharma, Inc. INZY | Glazer Capital, LLC | 4,251,940 6.590% | 4,251,940 (New Position) | Filing History |
| 2025-05-30 4:32 pm Purchase | 2025-05-27 | 13G | E2open Parent Holdings, Inc. ETWO | Glazer Capital, LLC | 22,614,623 7.270% | 22,614,623 (New Position) | Filing History |
| 2025-05-30 4:29 pm Purchase | 2025-05-23 | 13G | PHX Minerals Inc. PHX | Glazer Capital, LLC | 3,489,541 9.200% | 3,489,541 (New Position) | Filing History |
| 2025-05-20 2:20 pm Purchase | 2025-05-13 | 13G | Everi Holdings Inc. EVRI | Glazer Capital, LLC | 4,917,214 5.660% | 4,917,214 (New Position) | Filing History |
| 2025-05-15 4:35 pm Sale | 2025-03-31 | 13G | Zuora, Inc. ZUO | Glazer Capital, LLC | 0 0.000% | -8,372,609 (Position Closed) | Filing History |
| 2025-05-15 4:34 pm Sale | 2025-03-31 | 13G | TECHNOLOGY & TELECOMMUNICATION TETEF | Glazer Capital, LLC | 0 0.000% | -408,686 (Position Closed) | Filing History |
| 2025-05-15 4:33 pm Sale | 2025-03-31 | 13G | Revance Therapeutics, Inc. RVNC | Glazer Capital, LLC | 0 0.000% | -7,210,121 (Position Closed) | Filing History |
| 2025-05-15 4:32 pm Purchase | 2025-03-31 | 13G | Maywood Acquisition Corp. MAYA | Glazer Capital, LLC | 594,564 6.890% | 594,564 (New Position) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Logility Supply Chain Solutions, Inc. LGTY | Glazer Capital, LLC | 2,909,214 7.410% | 1,185,673 (+68.79%) | Filing History |
| 2025-05-15 4:29 pm Purchase | 2025-03-31 | 13G | Hennessy Capital Investment Corp. VII HVII | Glazer Capital, LLC | 1,027,505 5.220% | 1,027,505 (New Position) | Filing History |
| 2025-05-15 4:28 pm Sale | 2025-03-31 | 13G | EVERGREEN CORP EGRVF | Glazer Capital, LLC | 199,986 7.300% | -497,668 (-71.33%) | Filing History |
| 2025-05-15 4:25 pm Sale | 2025-03-31 | 13G | Embrace Change Acquisition Corp. EMCG | Glazer Capital, LLC | 79,885 1.770% | -150,115 (-65.27%) | Filing History |
| 2025-05-15 4:22 pm Purchase | 2025-03-31 | 13G | Dynamix Corporation DYNX | Glazer Capital, LLC | 1,025,006 6.170% | 1,025,006 (New Position) | Filing History |
| 2025-05-15 4:20 pm Sale | 2025-03-31 | 13G | Daseke, Inc. DSKE | Glazer Capital, LLC | 0 0.000% | -2,394,169 (Position Closed) | Filing History |
| 2025-05-15 4:17 pm Purchase | 2025-03-31 | 13G | Drugs Made In America Acquisition Corp. Ordinary Shares DMAA | Glazer Capital, LLC | 1,822,952 5.440% | 1,822,952 (New Position) | Filing History |
| 2025-05-15 4:14 pm Sale | 2025-03-31 | 13G | Innovid Corp. CTV | Glazer Capital, LLC | 0 0.000% | -7,841,568 (Position Closed) | Filing History |
| 2025-05-15 4:13 pm Purchase | 2025-03-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | Glazer Capital, LLC | 3,165,000 3.810% | 77,948 (+2.52%) | Filing History |
| 2025-05-15 4:07 pm Sale | 2025-03-31 | 13G | Avid Bioservices, Inc. CDMO | Glazer Capital, LLC | 0 0.000% | -3,394,114 (Position Closed) | Filing History |